Zimmer Biomet Holdings, Inc.
ZBH
Rang in aandelen
#1244
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing... Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.
Aandeelprijs
$95.94
Laatst gesynchroniseerd: 2026-10-20
Marktkapitalisatie
$18.30B
Verandering (1 dag)
0.92%
Verandering (1 jaar)
-6.57%
Land
US
Handel Zimmer Biomet Holdings, Inc. (ZBH)
Categorie
Healthcare
Winst voor Zimmer Biomet Holdings, Inc. (ZBH)
Winst in Jun 2026 TTM: $933.60M
Volgens de meest recente financiële verslagen van Zimmer Biomet Holdings, Inc. bedraagt de huidige winst van het bedrijf $933.60M. In 2024 behaalde het bedrijf een winst van $1.04B, een daling ten opzichte van de winst van 2023, die $1.07B bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Zimmer Biomet Holdings, Inc. van 2000 tot 2026
Winst aan het einde van elk jaar
| Jaar | Winst | Wijzigen |
|---|---|---|
| 2026 (TTM) | $933.60M | 12.37% |
| 2025 | $830.80M | -19.85% |
| 2024 | $1.04B | -2.88% |
| 2023 | $1.07B | 164.51% |
| 2022 | $403.50M | -19.14% |
| 2021 | $499.00M | -574.33% |
| 2020 | $-105.20M | -111.61% |
| 2019 | $905.80M | -434.12% |
| 2018 | $-271.10M | -158.35% |
| 2017 | $464.60M | 16.27% |
| 2016 | $399.60M | 160.84% |
| 2015 | $153.20M | -83.69% |
| 2014 | $939.40M | -4.25% |
| 2013 | $981.10M | -0.91% |
| 2012 | $990.10M | 1.14% |
| 2011 | $978.90M | 13.80% |
| 2010 | $860.20M | -13.82% |
| 2009 | $998.20M | -11.02% |
| 2008 | $1.12B | -0.87% |
| 2007 | $1.13B | -3.20% |
| 2006 | $1.17B | 12.33% |
| 2005 | $1.04B | 42.27% |
| 2004 | $731.50M | 67.20% |
| 2003 | $437.50M | 12.50% |
| 2002 | $388.90M | 61.44% |
| 2001 | $240.90M | -10.11% |
| 2000 | $268.00M | 0.00% |
Winst van vergelijkbare bedrijven of concurrenten
| Bedrijf | Winst | Winstverschil | Land |
|---|---|---|---|
| $7.51B | 704.52% |
US
|
|
| $5.56B | 495.87% |
IE
|
|
| $5.15B | 451.41% |
US
|
|
| $3.86B | 313.56% |
US
|
|
| - | - |
DE
|
